Description

I-Check Device – Enhancing Medication Safety in Healthcare

Objectives:

Reduce errors in injectable medication administration.
Improve reading accuracy and speed of medication labels.
Ensure consistent light levels in healthcare environments.
Raise awareness of the risks of misreading medications and promote error prevention strategies.

Background:

Errors in the administration of injectable medications are a significant concern for patients, healthcare providers, and organisations. Injectable medications carry a higher risk of errors due to their:

High-risk nature and rapid absorption into the system.
Limited space for labelling, making identification more difficult.
Fast-paced healthcare environments, where distractions are frequent.

The Signal Detection Theory offers insights into decision-making under stressful and distracting conditions, which can be applied to medication labelling. To address these challenges, the I-Check device was developed. It enhances medication labels using light, magnification, and colour contrast, improving readability and reducing the risk of medication errors.

Problem:

Research shows that healthcare settings often face:

Inconsistent light levels in areas where medications are prepared, checked, and administered.
Difficulty reading medication labels due to small print, glare, or poor contrast.
Frequent distractions and time pressures, increasing the chance of misinterpretation and dosing errors.

These issues compromise patient safety, putting pressure on healthcare providers and potentially leading to adverse events.

Solution:

The I-Check device was developed to overcome these challenges by:

Illuminating labels for improved visibility, even in low-light settings.
Providing magnification to assist in reading small text.
Utilising colour contrast to reduce confusion between similar-looking medications.

These features support healthcare professionals in administering medications safely and accurately.

Research Findings:

A randomised controlled trial (RCT) tested the impact of the I-Check device in a simulated setting. Key findings include:

Statistically significant improvements in reading speed for participants aged 24 and over.
Mixed methodology was used in a hospital-based trial, including:
- Quantitative measurement of light levels in areas where medication activities took place.
- Qualitative interviews with clinicians to understand their perspectives on reading medication labels and the usability of the I-Check device.
The hospital trial found that light levels often varied and did not consistently meet recommended standards.

Participants universally accepted the I-Check device, reporting that it enhanced their ability to read labels without interfering with their workflow.

Benefits of the I-Check Device:

Improved reading speed and accuracy in identifying medication labels.
Enhanced patient safety by reducing the chance of medication errors.
Universal acceptance among healthcare professionals without disrupting medication administration.
Improved awareness of the need for consistent light levels in medication preparation areas.

Conclusion:

The I-Check device has proven effective in enhancing the visibility of medication labels, improving reading speed, and reducing the risk of errors in administering injectable medications. By addressing environmental factors such as lighting and offering practical solutions like magnification and colour contrast, the I-Check supports safer, more efficient medication practices.

Healthcare providers can benefit from adopting the I-Check device to improve patient safety and streamline the administration of injectable medications.